280 related articles for article (PubMed ID: 33332330)
1. Drug-induced ocular inflammation.
Samalia P; Sims J; Niederer R
N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
[TBL] [Abstract][Full Text] [Related]
2. Brimonidine-associated uveitis - a descriptive case series.
Hopf S; Mercieca K; Pfeiffer N; Prokosch-Willing V
BMC Ophthalmol; 2020 Dec; 20(1):489. PubMed ID: 33334316
[TBL] [Abstract][Full Text] [Related]
3. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
Moore MM; Beith JM
Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
[No Abstract] [Full Text] [Related]
4. Uveitis Induced by Biological Agents Used in Cancer Therapy.
Deitch-Harel I; Raskin E; Habot-Wilner Z; Friling R; Amer R; Kramer M
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1370-1374. PubMed ID: 32546073
[No Abstract] [Full Text] [Related]
5. Zoledronic acid induced unilateral anterior uveitis.
Gupta S; Onkar A; Vashisht T
Indian J Ophthalmol; 2020 Sep; 68(9):2002-2003. PubMed ID: 32823458
[TBL] [Abstract][Full Text] [Related]
6. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
French DD; Margo CE
Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
[TBL] [Abstract][Full Text] [Related]
7. Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.
Patel DV; Bolland M; Nisa Z; Al-Abuwsi F; Singh M; Horne A; Reid IR; McGhee CN
Osteoporos Int; 2015 Feb; 26(2):499-503. PubMed ID: 25187119
[TBL] [Abstract][Full Text] [Related]
8. Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature.
Jin X; Shou Z; Shao Y; Bian P
Arch Osteoporos; 2021 Jun; 16(1):104. PubMed ID: 34180015
[TBL] [Abstract][Full Text] [Related]
9. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F
BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651
[TBL] [Abstract][Full Text] [Related]
10. Brimonidine Induced Anterior Uveitis.
Beltz J; Zamir E
Ocul Immunol Inflamm; 2016; 24(2):128-33. PubMed ID: 26399160
[TBL] [Abstract][Full Text] [Related]
11. Ocular Side Effects of Bisphosphonates: A Review of Literature.
Chartrand NA; Lau CK; Parsons MT; Handlon JJ; Ronquillo YC; Hoopes PC; Moshirfar M
J Ocul Pharmacol Ther; 2023; 39(1):3-16. PubMed ID: 36409537
[TBL] [Abstract][Full Text] [Related]
12. The incidence of acute anterior uveitis after intravenous zoledronate.
Patel DV; Horne A; House M; Reid IR; McGhee CN
Ophthalmology; 2013 Apr; 120(4):773-6. PubMed ID: 23290982
[TBL] [Abstract][Full Text] [Related]
13. Zoledronate-induced anterior uveitis, scleritis and optic neuritis: a case report.
Wolpert LE; Watts AR
N Z Med J; 2021 Jun; 134(1537):91-94. PubMed ID: 34239165
[No Abstract] [Full Text] [Related]
14. Anterior uveitis complicating zoledronic acid infusion.
Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
[TBL] [Abstract][Full Text] [Related]
15. Scleritis and other ocular side effects associated with pamidronate disodium.
Fraunfelder FW; Fraunfelder FT; Jensvold B
Am J Ophthalmol; 2003 Feb; 135(2):219-22. PubMed ID: 12566027
[TBL] [Abstract][Full Text] [Related]
16. Uveitis in patients with late-stage cutaneous melanoma treated with vemurafenib.
Guedj M; Quéant A; Funck-Brentano E; Kramkimel N; Lellouch J; Monnet D; Longvert C; Gantzer A; Brézin AP
JAMA Ophthalmol; 2014 Dec; 132(12):1421-5. PubMed ID: 25125216
[TBL] [Abstract][Full Text] [Related]
17. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
Umunakwe OC; Herren D; Kim SJ; Kohanim S
Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
[TBL] [Abstract][Full Text] [Related]
18. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database.
Anquetil C; Salem JE; Lebrun-Vignes B; Touhami S; Desbois AC; Maalouf G; Domont F; Allenbach Y; Cacoub P; Bodaghi B; Saadoun D
J Autoimmun; 2020 Jul; 111():102454. PubMed ID: 32303423
[TBL] [Abstract][Full Text] [Related]
19. [Bisphosphonate-induced ocular and orbital inflammation].
Jakobsen TS; Funding M
Ugeskr Laeger; 2022 Jul; 184(28):. PubMed ID: 35959811
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-associated scleritis: a case report and review.
Leung S; Ashar BH; Miller RG
South Med J; 2005 Jul; 98(7):733-5. PubMed ID: 16108245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
